Repligen

Repligen's CEO Discusses Q1 2013 Results - Earnings Call Transcript

Repligen's CEO Discusses Q1 2013 Results - Earnings Call Transcript

Seeking Alpha

3 Ways Big Pharma Is Seizing This Rare Opportunity

3 Ways Big Pharma Is Seizing This Rare Opportunity

Motley Fool

Repligen Promises To Be A Cash Flow Machine

Repligen Promises To Be A Cash Flow Machine

Seeking Alpha

Repligen

Repligen forms partnership on spinal muscle drug

Repligen forms partnership on spinal muscle drug

Yahoo/AP

Repligen will work with Pfizer to develop drug to treat for Spinal Muscular Atrophy

Repligen will work with Pfizer to develop drug to treat for Spinal Muscular Atrophy

Yahoo/AP

Repligen Corp Third Quarter Earnings Sneak Peek

Repligen Corp Third Quarter Earnings Sneak Peek

Wall St. Cheat Sheet

Repligen Earnings: Beats Wall Street Expectations

Repligen Earnings: Beats Wall Street Expectations

Wall St. Cheat Sheet

Healthcare Biz Recap: J&J Blocked, Repligen Craters, Arena AXED

Healthcare Biz Recap: J&J Blocked, Repligen Craters, Arena AXED

Wall Street Cheat Street

Bio-Pharma Catalyst Trades And ASCO Movers: Making The Grade

Bio-Pharma Catalyst Trades And ASCO Movers: Making The Grade

Seeking Alpha

Repligen Corp Earnings: Significant Revenue Growth

Repligen Corp Earnings: Significant Revenue Growth

Wall St. Cheat Sheet